RECRUITING

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

Official Title

NeoChemoPRT: a Randomized Study of Resistance Training and Post-Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Quick Facts

Study Start:2025-01-02
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06858449

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years to 89 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 20-89 years
  2. 2. Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
  3. 3. Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
  4. 4. Must be able to read and understand English and consent for themselves.
  1. 1. Inability to get up and down off the ground or squat body weight
  2. 2. Inability to safely engage in group exercise sessions as deemed by study PI
  3. 3. Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
  4. 4. Lactose intolerance
  5. 5. Cow's milk or whey protein allergy
  6. 6. Pregnant women
  7. 7. Males

Contacts and Locations

Study Contact

Clinical Trials Contact
CONTACT
412-330-6151
ctgov@ahn.org

Principal Investigator

Colin Champ, MD
PRINCIPAL_INVESTIGATOR
AHN Radiation Oncology

Study Locations (Sites)

Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
United States

Collaborators and Investigators

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

  • Colin Champ, MD, PRINCIPAL_INVESTIGATOR, AHN Radiation Oncology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-02
Study Completion Date2026-03

Study Record Updates

Study Start Date2025-01-02
Study Completion Date2026-03

Terms related to this study

Keywords Provided by Researchers

  • exercise
  • resistance training

Additional Relevant MeSH Terms

  • Cancer
  • Breast Cancer